Diplomat Pharmacy, Inc.·4

Jun 5, 4:15 PM ET

DREYER DAVID C 4

4 · Diplomat Pharmacy, Inc. · Filed Jun 5, 2019

Insider Transaction Report

Form 4
Period: 2019-06-03
Transactions
  • Sale

    Common Stock

    2019-06-04$4.85/sh1,274$6,18540,987 total
  • Award

    Common Stock

    2019-06-03+20,67442,261 total
Footnotes (3)
  • [F1]The shares of restricted stock were granted in connection with the Issuer's non-employee director compensation program.
  • [F2]The sales reported in this Form 4 represent shares sold to cover the tax liability incurred incident to the vesting of previously granted restricted stock.
  • [F3]The price represents the weighted average price of the multiple transactions reported on this line. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT